Lessee, Operating Lease, Liability, to be Paid of Transcode Therapeutics, Inc. from 30 Jun 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Transcode Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Jun 2021 to 31 Dec 2024.
  • Transcode Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $38,291, a 92% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $38,291 -$422,464 -92% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $153,508 -$456,388 -75% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $230,320 -$454,146 -66% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $345,537 -$450,784 -57% 31 Mar 2024 10-Q 15 May 2024 2023 Q3
Q4 2023 $460,755 31 Dec 2023 10-K 01 Apr 2024 2023 FY
Q3 2023 $609,896 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $684,466 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $796,321 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2021 $18,630 31 Dec 2021 10-K 31 Mar 2022 2021 FY
Q3 2021 $46,575 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $74,520 30 Jun 2021 10-Q 23 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.